Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma subtype, and approximately 50% of the patients are >60 years of age. Patients with relapsed/refractory (rr) disease have a poor prognosis with currently available treatments. Lenalidomide is available in Italy for patients with rrDLBCL based on a local disposition of the Italian Drug Agency.

Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice

Broccoli, Alessandro;Casadei, Beatrice;Tani, Monica;Musuraca, Gerardo;Romano, Alessandra;Argnani, Lisa;Zinzani, Pier Luigi
2019

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma subtype, and approximately 50% of the patients are >60 years of age. Patients with relapsed/refractory (rr) disease have a poor prognosis with currently available treatments. Lenalidomide is available in Italy for patients with rrDLBCL based on a local disposition of the Italian Drug Agency.
2019
Broccoli, Alessandro; Casadei, Beatrice; Chiappella, Annalisa; Visco, Carlo; Tani, Monica; Cascavilla, Nicola; Conconi, Annarita; Balzarotti, Monica; Cox, Maria Christina; Marino, Dario; Goldaniga, Maria Cecilia; Marasca, Roberto; Tecchio, Cristina; Patti, Caterina; Musuraca, Gerardo; Devizzi, Liliana; Monaco, Federico; Romano, Alessandra; Fama, Angelo; Zancanella, Michelle; Paolini, Rossella; Rigacci, Luigi; Castellino, Claudia; Gaudio, Francesco; Argnani, Lisa; Zinzani, Pier Luigi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/684897
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact